Bittianda Kuttapa Thelma | |
---|---|
Born | 1955 (age 67–68) |
Nationality | Indian |
Alma mater | Bangalore University, University of Delhi |
Known for | Human Genetics |
Scientific career | |
Fields | Cytogenetics and Human Genetics |
Institutions | Department of Genetics, University of Delhi |
B K Thelma commonly known as Bittianda Kuttapa Thelma is a professor in the Department of Genetics at the University of Delhi, South Campus, New Delhi, India. She is the Principal investigator and Co-ordinator of the Centre of excellence on Genomes Sciences and Predictive Medicine funded by the Govt. of India. She is also the Co-ordinator of a major project on newborn screening for inborn errors of metabolism in Delhi state which aims to demonstrate the feasibility of mandatory screening of newborns in the country and to generate epidemiological data for the testable IEMs in the genetically distinct Indian population, for the first time.
Discovery genomics is the major thrust of her research and ongoing projects include genetic analysis of complex traits including brain and inflammatory disorders and Mendelian forms of neurological and neuropsychiatric diseases. Her most recent engagement is in the area of Ayurgenomics wherein individuals can be deep phenotyped based on the principles of Ayurveda to obtain homogeneous case-control cohorts to be used for disease gene mapping. This approach is expected to overcome the issue of clinical/phenotypic heterogeneity which is a major limitation in contemporary complex trait genetics research. [1]
Her recent academic accomplishments include i) identification of novel risk genes/loci for two inflammatory conditions namely Rheumatoid arthritis & Ulcerative colitis by the first ever GWAS conducted in the genetically distinct north Indian population; ii) discovery of new causal genes namely MID2 for X-linked Intellectual Disability; PODXL and RIC3 genes for familial Parkinson's disease by exome sequencing approach; and iii) demonstration of differences/similarities between the two major Indian subpopulations namely south and north Indians using both SNP array based and exome sequencing approaches. She has several national and international collaborative projects and has over 90 peer reviewed publications to her credit. She is a fellow of all the three science academies in India, has served as a member of the Scientific Advisory Council to the Prime Minister of India; National Science and Engineering Research Board and Human Genetics/Medical genomics task force of funding agencies including the Department of Biotechnology and Indian council of Medical research, Government of India. Delhi. She has taught subjects like Human Genetics, Human and Medical Biotechnology, Cytogenetics, Recombinant DNA technology, Prokaryotic and Eukaryotic gene expression, Molecular systematics and evolution, and Cell biology. [2] [3] Her recent publication, Attempts to replicate genetic associations with schizophrenia in a cohort from north India was published in Nature. [4] As of Dec 2019, she has 5135 citation on google scholar, [5] with an h-index of 34 and i10 index of 77. [6]
Thelma completed her BSc and MSc in zoology from Bangalore University in 1973 and 1975 respectively. [3] She pursued PhD in biomedical research in 1982 from the University of Delhi. [3] Thelma had a short stint as postdoctoral fellow in the Human Genetics Laboratory at Children's Hospital, Switzerland with Professor Hans Jakob Muller. She was CSIR Pool Officer and Research Associate in the Zoology Department, University of Delhi. In 1987, she started as a lecturer at Department of Genetics, University of Delhi South Campus. She has also been a visiting scientist at prestigious institutions abroad and undertook several international research collaborations. Thelma established the DNA-based diagnosis facilities for fragile X syndrome, the most common form of inherited intellectual disability, with financial support from Department of Biotechnology. Her lab is one of the few which offers this national level diagnostic service. She also served on various expert committees of ICMR, DBT, and CSIR. and as Member of the XV International Genetics Congress Trust. [7] Thelma has worked on 197 publications as of Dec 2019 according to her google scholar page. [8]
Thelma has extensively worked on Human genetics and Medical genomics. Her areas of specialisation and interest include:
Thelma has been recognised for her work. She has received many awards, some of her accomplishments are:
Genomic convergence is a multifactor approach used in genetic research that combines different kinds of genetic data analysis to identify and prioritize susceptibility genes for a complex disease.
Mary-Claire King is an American geneticist. She was the first to show that breast cancer can be inherited due to mutations in the gene she called BRCA1. She studies human genetics and is particularly interested in genetic heterogeneity and complex traits. She studies the interaction of genetics and environmental influences and their effects on human conditions such as breast and ovarian cancer, inherited deafness, schizophrenia, HIV, systemic lupus erythematosus and rheumatoid arthritis. She has been the American Cancer Society Professor of the Department of Genome Sciences and of Medical Genetics in the Department of Medicine at the University of Washington since 1995.
The nuclear receptor 4A2 (NR4A2) also known as nuclear receptor related 1 protein (NURR1) is a protein that in humans is encoded by the NR4A2 gene. NR4A2 is a member of the nuclear receptor family of intracellular transcription factors.
CSIR Institute of Genomics and Integrative Biology (CSIR-IGIB) is a scientific research institute devoted primarily to biological research. It is a part of Council of Scientific and Industrial Research (CSIR), India.
Exome sequencing, also known as whole exome sequencing (WES), is a genomic technique for sequencing all of the protein-coding regions of genes in a genome. It consists of two steps: the first step is to select only the subset of DNA that encodes proteins. These regions are known as exons—humans have about 180,000 exons, constituting about 1% of the human genome, or approximately 30 million base pairs. The second step is to sequence the exonic DNA using any high-throughput DNA sequencing technology.
Stephen Wayne "Steve" Scherer is a Canadian scientist who studies genetic variation in human disease. He obtained his PhD at the University of Toronto under Professor Lap-chee Tsui. Together they founded Canada's first human genome centre, the Centre for Applied Genomics (TCAG) at the Hospital for Sick Children. He continues to serve as director of TCAG, and is also a University Professor in the Department of Molecular Genetics, and the director of the McLaughlin Centre at the Temerty Faculty of Medicine at the University of Toronto.
Rajeev Kumar Varshney is an agricultural scientist, specializing in genomics, genetics, molecular breeding and capacity building in developing countries. Varsheny is currently the Research Program Director- Genetic Gains that includes several units viz. Genomics & Trait Discovery, Forward Breeding, Pre-Breeding, Cell, Molecular Biology & Genetic Engineering, Seed Systems, Biotechnology- ESA, Sequencing and Informatics Services Unit, and Genebank ; and Director, Center of Excellence in Genomics & Systems Biology at the International Crops Research Institute for the Semi-Arid Tropics (ICRISAT), a global agricultural research institute. He holds Adjunct/Honorary/Visiting Professor positions at 10 academic institutions in Australia, China, Ghana, Hong Kong and India, including Murdoch University, The University of Western Australia, University of Queensland, West Africa Centre for Crop Improvement, University of Hyderabad, Chaudhary Charan Singh University and Professor Jayashankar Telangana State Agricultural University.
Dr. Vinod Scaria FRSB, FRSPH is an Indian biologist, medical researcher pioneering in Precision Medicine and Clinical Genomics in India. He is best known for sequencing the first Indian genome. He was also instrumental in the sequencing of The first Sri Lankan Genome, analysis of the first Malaysian Genome sequencing and analysis of the Wild-type strain of Zebrafish and the IndiGen programme on Genomics for Public Health in India
Joseph D. Buxbaum is an American molecular and cellular neuroscientist, autism researcher, and the Director of the Seaver Autism Center at the Icahn School of Medicine at Mount Sinai. Buxbaum is also, along with Simon Baron-Cohen, the co-editor of the BioMed Central journal Molecular Autism, and is a member of the scientific advisory board of the Autism Science Foundation. Buxbaum is a Professor of Psychiatry, Neuroscience, and Genetics and Genomic Sciences. He is also the Vice Chair for Research and for Mentoring in the Department of Psychiatry at the Icahn School of Medicine at Mount Sinai.
Usha Vijayraghavan is on the faculty of the Department of Microbiology and Cell Biology, at the Indian Institute of Science. Her major research interests are Molecular Genetics, Plant Development.
Mitali Mukerji is a Professor and Head of the Department of Bioscience and Bioengineering, IIT Jodhpur. She was formerly a Chief Scientist at the CSIR Institute of Genomics and Integrative Biology with notable achievement in the field of human genomics and personalized medicine. She is best known for initiating the field of "Ayurgenomics" in partnership with her colleague Dr. Bhavana Prasher under the mentorship of Prof. Samir K. Brahmachari. Ayurgenomics is an innovative study, blending the principles of Ayurveda- the traditional Indian system of medicine- with genomics. Mukerji is also a major contributor in the Indian Genome Variation Consortium, a comprehensive database that is producing "the first genetic landscape of the Indian population", and has been an author in many publications that use IGV databases to study population genomics. Mukerji has done extensive research on hereditary ataxias, and is involved in many other projects related to tracking disease origins and mutational histories. She is the recipient of the prestigious Shanti Swarup Bhatnagar Award in 2010 for her contribution in the field of Medical Sciences.
Karen L. Mohlke is a biologist at University of North Carolina, Chapel Hill. She is known for her work in human genetics, especially in the area of diabetes research. She was one of the first researchers to use exome array genotyping.
Paramjit Khurana is an Indian scientist in Plant Biotechnology, Molecular Biology, Genomics who is presently Professor in the Department of Plant Molecular Biology in the University of Delhi, Delhi. She has received many awards and published more than 125 scientific papers.
Katherine Belov is an Australian geneticist, professor of comparative genomics in the School of Life and Environmental Sciences and Pro Vice Chancellor of Global Engagement at the University of Sydney. She is head of the Australasian Wildlife Genomics Group and research expert in the area of comparative genomics and immunogenetics, including Tasmanian devils and koalas, two iconic Australian species that are threatened by disease processes. Throughout her career, she has disproved the idea that marsupial immune system is primitive, characterized the South American gray short-tailed opossum's immune genes, participated in the Platypus Genome Project, led research identifying the properties of platypus venom, and identified the cause of the spread of the Tasmanian devil's contagious cancer.
Narinder Kumar Mehra is an Indian immunologist, head of the department of transplant immunology and immunogenetics of the SRL Limited, Gurgaon. He is a former dean of research and holds the ICMR Dr. C.G. Pandit National Chair at AIIMS. An elected fellow of the International Medical Sciences Academy, The World Academy of Sciences, Indian National Science Academy and National Academy of Sciences, India, Mehra is known for his research on histocompatibility and immunogenetics. The Council of Scientific and Industrial Research, the apex agency of the Government of India for scientific research, awarded him the Shanti Swarup Bhatnagar Prize for Science and Technology, one of the highest Indian science awards for his contributions to Medical Sciences in 1992. He received the Chevalier of the National Order of Merit from François Mitterrand in 2003.
Subramaniam Ganesh is an Indian geneticist, molecular biologist and a professor at the department of biological sciences and bio-engineering of the Indian Institute of Technology, Kanpur. Known for his pioneering studies on Lafora progressive myoclonic epilepsy and other neurodegenerative disorders, Ganesh is an elected fellow of the Indian Academy of Sciences and the National Academy of Sciences, India. The Department of Biotechnology of the Government of India awarded him the National Bioscience Award for Career Development, one of the highest Indian science awards, for his contributions to biosciences in 2008.
Nicole Soranzo is an Italian-British senior group leader in human genetics at the Wellcome Sanger Institute, Professor of Human Genetics at the University of Cambridge. She is an internationally recognised Human Geneticist who has focused on the application of cutting edge genomic technologies to study the spectrum of human genetic variation associated with cardio-metabolic and immune diseases. She has led many large-scale discovery efforts including more than 1,000 novel genetic variants associated with cardio-metabolic diseases and their risk factors as well as establishing the HaemGen consortium, which is a worldwide effort to discover genetic determinants of blood cell formation and also interpretation of the downstream consequences of sequence variation through a host of integrative analyses and functional approaches.
Josée Dupuis is a Canadian biostatistician. She is a professor in the Boston University School of Public Health, where she chairs the department of biostatistics. Her research interests include genome-wide association studies, gene–environment interaction, and applications to diabetes and cardiovascular disease.
Diana Prata is a Portuguese neuroscientist who concentrates on identifying the biological basis of human behaviour. She reported the first evidence that schizophrenia-risk genes can also predispose to bipolar disorder and has also investigated reasons why people respond differently to antipsychotic medications. She is head of the Biomedical Neuroscience Lab at the University of Lisbon.
Personalized genomics is the human genetics-derived study of analyzing and interpreting individualized genetic information by genome sequencing to identify genetic variations compared to the library of known sequences. International genetics communities have spared no effort from the past and have gradually cooperated to prosecute research projects to determine DNA sequences of the human genome using DNA sequencing techniques. The methods that are the most commonly used are whole exome sequencing and whole genome sequencing. Both approaches are used to identify genetic variations. Genome sequencing became more cost-effective over time, and made it applicable in the medical field, allowing scientists to understand which genes are attributed to specific diseases.
{{cite web}}
: CS1 maint: url-status (link)